Advertisement
-
1
Pereira de Godoy JM, Vasconcelos Ribeiro J, Caracanhas LA: Mortality and diabetes mellitus in amputations of the lower limbs for gas gangrene: a case report. Int J Low Extrem Wounds 7: 239, 2008.
-
2
Kuy S, Romero RA, Kuy S: Gas gangrene of the diabetic foot. J La State Med Soc 167: 213, 2015.
-
3
Dinubile MJ: Complicated infections of skin and skin structures: when the infection is more than skin deep. J Antimicrob Chemother 53(suppl 2): ii37, 2004.
-
4
Brucato MP, Patel K, Mgbako O: Diagnosis of gas gangrene: does a discrepancy exist between the published data and practice. J Foot Ankle Surg 53: 137, 2014.
-
5
Bessman AN: Nonclostridial gas gangrene. JAMA 233: 958, 1975.
-
6
Nichols RL, Smith JW: Gas in the wound: what does it mean? Surg Clin North Am 55: 1289, 1975.
-
7
Weinstein L, Barza MA: Gas gangrene. N Engl J Med 289: 1129, 1973.
-
8
Andrews FW, Horder, TJ: A study of the streptococci pathogenic for man. III. Proposed classification of streptococci based upon all characters and including Gordon's tests. Lancet 2: 711, 1906.
-
9
Cooper JD, Gotoff RA: Streptococcus anginosus purulent pericarditis with contiguous hepatic and subdiaphragmatic fluid collections: first reported case. Infect Dis Clin Pract 24: e37, 2016.
-
10
Siegman-Igra Y, Azmon Y, Schwartz D: Milleri group streptococcus: a stepchild in the viridans family. Eur J Clin Microbiol Infect Dis 31: 2453, 2012.
-
11
Facklam R: What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev 15: 613, 2002.
-
12
Gossling J: Occurrence and pathogenicity of the Streptococcus milleri group. Clin Infect Dis 10: 257, 1988.
-
13
Piscitelli SC, Shwed J, Schreckenberger P, et al: Streptococcus milleri group: renewed interest in an elusive pathogen. Eur J Clin Microbiol Infect Dis 11: 491, 1992.
-
14
Whiley RA, Beighton D: Emended descriptions and recognition of Streptococcus constellatus, Streptococcus intermedius, and Streptococcus anginosus as distinct species. Int J Syst Bacteriol 41: 1, 1991.
-
15
Asam D, Spellerberg B: Molecular pathogenicity of Streptococcus anginosus. Mol Oral Microbiol 29: 145, 2014.
-
16
Wanahita A, Goldsmith EA, Musher DM, et al: Interaction between human polymorphonuclear leukocytes and Streptococcus milleri group bacteria. J Infect Dis 185: 85, 2002.
-
17
Claridge JE III, Attorri S, Musher DM, et al: Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (“Streptococcus milleri group”) are of different clinical importance and are not equally associated with abscess. Clin Infect Dis 32: 1511, 2001.
A Rare Case of Myonecrosis with Soft-Tissue Emphysema in a Diabetic Foot Caused by Streptococcus anginosus Isolated in Pure Culture: A Case Study
Search for other papers by Jack Route in
Current site
Google Scholar
PubMed
Search for other papers by Joseph Anain Jr in
Current site
Google Scholar
PubMed
Streptococcus anginosus (SAG) is a known human pathogen and member of the Streptococcus milleri group. SAG is a known bacterial cause of soft-tissue abscesses and bacteremia and is an increasingly prevalent pathogen in infections in patients with cystic fibrosis. We describe a rare case of SAG as an infectious agent in a case of nonclostridial myonecrosis with soft-tissue emphysema. This is the only case found in the literature of SAG cultured as a pure isolate in this type of infection and was associated with a prolonged course of treatment in an otherwise healthy patient.
